|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-11-24 Purchase |
2008-11-24 7:07 pm | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 64,000 | $15.5 | $992,140 | 191,830 (Indirect) | View |
| 2008-06-02 Purchase |
2008-06-03 09:13 am | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 27,600 | $36.16 | $998,016 | 127,830 (Indirect) |
View |
| 2004-09-02- -2004-09-03 Purchase |
2004-09-03 9:00 pm |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director 10% owner) | 10,000 | $15.78 | $157,760 | 1,383,689 (Indirect) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2008-11-21 Other | 2008-11-24 7:07 pm | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 2,000,000 | $7.4e+05 | $1,480,000,000,000 | 1,000,000 (Indirect) |
View |
| 2008-06-09 Option Award |
2008-06-10 5:00 pm | AMAG PHARMACEUTICALS INC. | AMAG | ZWANZIGER RON (Director) | 2,500 | $38.95 | $97,362 | 2,500 (Indirect) | View |
| 2006-12-19 Exercise | 2007-01-23 5:21 pm |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 213,321 | $17.15 | $3,658,455 | 1,769,902 (Indirect) | View |
| 2005-02-28 Exercise | 2005-03-02 7:25 pm | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director 10% owner) | 4,485 | $1.24 | $5,561 | 266,935 (Direct) | View |
| 2004-12-08 Purchase | 2004-12-10 12:32 pm | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON ZWANZIGER FAMILY VENTURES LLC (Chairman, CEO & President Director 10% owner) | 172,892 | $17.45 | $3,016,965 | 1,556,581 (Indirect) |
View |
| Transaction & Date | Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership | Filing |
| 2008-12-19 Option Award | 2008-12-22 4:53 pm |
N/A 2018-12-19 |
AMAG PHARMACEUTICALS INC. | AMAG | ZWANZIGER RON (Director) | 5,000 | $32.27 | 5,000 (Direct) |
View |
| 2008-11-24 Purchase |
2008-11-24 7:07 pm |
2008-11-24 2016-05-15 | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 1,600,000 | $43.98 | 1,600,000 (Indirect) | View |
| 2008-11-24 Purchase |
2008-11-24 7:07 pm | N/A N/A | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 15 | $69.32 | 15 (Indirect) |
View |
| 2008-11-24 Purchase | 2008-11-24 7:07 pm | N/A N/A |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 700 | $69.32 | 715 (Indirect) | View |
| 2008-11-24 Purchase | 2008-11-24 7:07 pm |
N/A N/A |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 2,000 | $69.32 | 2,715 (Indirect) | View |
| 2008-11-24 Purchase | 2008-11-24 7:07 pm |
N/A N/A | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 3,000 | $69.32 | 5,715 (Indirect) |
View |
| 2008-11-24 Purchase |
2008-11-24 7:07 pm |
N/A N/A |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 1,000 | $69.32 | 6,715 (Indirect) |
View |
| 2008-11-24 Purchase | 2008-11-24 7:07 pm |
N/A N/A |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 2,000 | $69.32 | 8,715 (Indirect) |
View |
| 2008-11-24 Purchase |
2008-11-24 7:07 pm |
N/A N/A | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 1,000 | $69.32 | 9,715 (Indirect) |
View |
| 2008-07-23 Option Award | 2008-07-29 4:31 pm |
N/A 2018-07-22 |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 150,000 | $61.49 | 150,000 (Direct) | View |
| 2007-11-27 Option Award | 2007-11-29 6:00 pm | N/A 2017-11-27 |
AMAG PHARMACEUTICALS INC. | AMAG | ZWANZIGER RON (Director) | 3,216 | $53.98 | 3,216 (Direct) |
View |
| 2007-05-17 Option Award |
2007-05-21 4:12 pm | N/A 2017-05-16 |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 300,000 | $39.72 | 300,000 (Direct) |
View |
| 2006-12-19 Exercise | 2007-01-23 5:21 pm | N/A 2006-12-19 |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director) | 385,000 | $17.15 | 0 (Indirect) |
View |
| 2006-11-07 Option Award | 2006-11-09 5:14 pm | 2007-11-07 2016-11-07 |
ADVANCED MAGNETICS INC | AMAG | ZWANZIGER RON (Director) | 8,801 | $41.16 | 8,801 (Direct) | View |
| 2005-02-28 Exercise | 2005-03-02 7:25 pm | 2001-11-21 2005-10-17 |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director 10% owner) | 4,485 | $1.24 | 0 (Direct) | View |
| 2004-12-08 Purchase |
2004-12-10 12:32 pm | 2002-09-20 2008-09-20 | INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON ZWANZIGER FAMILY VENTURES LLC (Chairman, CEO & President Director 10% owner) | 3,000,000 | $17.45 | 0 (Indirect) | View |
| 2003-12-31 Option Award | 2004-01-05 6:39 pm | 2003-12-31 2013-12-30 |
INVERNESS MEDICAL INNOVATIONS INC | IMA | ZWANZIGER RON (Chairman, CEO & President Director 10% owner) | 7,576 | $21.78 | 7,576 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 20 Nov 2009 22:00:31 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |